SU2C phase Ib study of pan-PI3K inhibitor BKM120 with letrozole in ER+/HER2- metastatic breast cancer (MBC).
Ingrid A. Mayer
Research Funding - Novartis
Vandana Gupta Abramson
No relevant relationships to disclose
Justin M. Balko
No relevant relationships to disclose
Steven J. Isakoff
No relevant relationships to disclose
Maria Gabriela Kuba
No relevant relationships to disclose
Melinda Sanders
No relevant relationships to disclose
Andres Forero-Torres
No relevant relationships to disclose
Jeffrey T. Yap
No relevant relationships to disclose
Annick D. Van Den Abbeele
No relevant relationships to disclose
Yisheng Li
No relevant relationships to disclose
Carlos L. Arteaga
No relevant relationships to disclose
Eric P. Winer
No relevant relationships to disclose